Pacer Advisors, Inc. Medpace Holdings, Inc. Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 8,869 shares of MEDP stock, worth $3.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,869

Previous 13,968 36.5%

Holding current value

$3.09 Million

Previous $5.75 Million 48.59%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$320.58 - $457.29 $1.63 Million - $2.33 Million	-5,099 Reduced 36.5%	8,869 $2.96 Million
Q2 2024 Aug 13, 2024	BUY	$372.0 - $424.34 $3.36 Million - $3.83 Million	9,022 Added 182.41%	13,968 $5.75 Million
Q1 2024 May 10, 2024	BUY	$284.87 - $413.31 $410,497 - $595,579	1,441 Added 41.11%	4,946 $2 Million
Q4 2023 Jan 16, 2024	SELL	$227.52 - $312.68 $463,230 - $636,616	-2,036 Reduced 36.74%	3,505 $1.07 Million
Q3 2023 Nov 13, 2023	SELL	$233.98 - $281.67 $200,520 - $241,391	-857 Reduced 13.39%	5,541 $1.34 Million
Q2 2023 Jul 12, 2023	BUY	$187.26 - $240.17 $758,403 - $972,688	4,050 Added 172.49%	6,398 $1.54 Million
Q1 2023 May 02, 2023	SELL	$174.31 - $239.52 $433,334 - $595,446	-2,486 Reduced 51.43%	2,348 $441,000
Q4 2022 Feb 06, 2023	BUY	$153.06 - $226.57 $465,761 - $689,452	3,043 Added 169.91%	4,834 $1.03 Million
Q3 2022 Oct 18, 2022	BUY	$145.13 - $182.49 $203,472 - $255,850	1,402 Added 360.41%	1,791 $281,000
Q2 2022 Aug 12, 2022	BUY	$130.2 - $168.03 $5,989 - $7,729	46 Added 13.41%	389 $58,000
Q1 2022 Apr 05, 2022	SELL	$138.87 - $214.31 $626,164 - $966,323	-4,509 Reduced 92.93%	343 $56,000
Q4 2021 Feb 03, 2022	BUY	$182.74 - $227.9 $310,658 - $387,430	1,700 Added 53.93%	4,852 $1.06 Million
Q3 2021 Oct 15, 2021	BUY	$170.18 - $198.21 $6,466 - $7,531	38 Added 1.22%	3,152 $597,000
Q2 2021 Jul 21, 2021	SELL	$158.62 - $194.3 $2,220 - $2,720	-14 Reduced 0.45%	3,114 $550,000
Q1 2021 Apr 05, 2021	BUY	$132.02 - $168.26 $3,168 - $4,038	24 Added 0.77%	3,128 $513,000
Q4 2020 Jan 20, 2021	SELL	$109.38 - $149.19 $347,062 - $473,379	-3,173 Reduced 50.55%	3,104 $432,000
Q3 2020 Oct 19, 2020	BUY	$92.95 - $130.61 $583,447 - $819,838	6,277 New	6,277 $701,000
Q1 2020 Apr 23, 2020	SELL	$61.71 - $101.95 $464,923 - $768,091	-7,534 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$70.08 - $84.64 $527,982 - $637,677	7,534 New	7,534 $633,000
Q3 2019 Oct 10, 2019	SELL	$62.38 - $85.89 $659,107 - $907,513	-10,566 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$53.64 - $65.42 $34,758 - $42,392	-648 Reduced 5.78%	10,566 $691,000
Q1 2019 Apr 10, 2019	BUY	$49.38 - $70.58 $553,747 - $791,484	11,214 New	11,214 $661,000

Others Institutions Holding MEDP

# of Institutions

617

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Medpace Holdings, Inc. Transaction History